A S Salinas Sanchez

Summary

Country: Spain

Publications

  1. Salinas Sanchez A, Sanchez Sanchez F, Donate Moreno M, Rubio Del Campo A, Serrano Oviedo L, Giménez Bachs J, et al. GSTT1, GSTM1, and CYP1B1 gene polymorphisms and susceptibility to sporadic renal cell cancer. Urol Oncol. 2012;30:864-70 pubmed publisher
    ..Patients with GSTT1 deletion had tumors of more advanced stages, and those with Val432 polymorphism in CYP1B1 had tumors of higher Fuhrman grade. ..
  2. Salinas Sanchez A, Donate Moreno M, Lopez Garrido M, Giménez Bachs J, Escribano J. Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility. J Urol. 2012;187:700-6 pubmed publisher
    ..2 to 8.3. This study provides strong evidence for the role of common CYP1B1 variants as risk factors for bladder cancer, which increases with occupational exposure. ..
  3. Salinas Sanchez A, Hernández Millán I, Virseda Rodriguez J, Segura Martin M, Lorenzo Romero J, Giménez Bachs J, et al. [Problem-based learning in urology training. The Faculty of Medicine of the Universidad de Castilla-La Mancha model]. Actas Urol Esp. 2005;29:8-15 pubmed
    ....
  4. Salinas Sanchez A, Lorenzo Romero J, Giménez Bachs J, Sanchez Sanchez F, Donate Moreno M, Rubio Del Campo A, et al. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study. Urol Oncol. 2008;26:620-6 pubmed publisher
    ..Nevertheless, the classic prognostic factors (primarily, pTNM stage) should still be considered the most useful factors for follow-up of these patients. ..

Detail Information

Publications4

  1. Salinas Sanchez A, Sanchez Sanchez F, Donate Moreno M, Rubio Del Campo A, Serrano Oviedo L, Giménez Bachs J, et al. GSTT1, GSTM1, and CYP1B1 gene polymorphisms and susceptibility to sporadic renal cell cancer. Urol Oncol. 2012;30:864-70 pubmed publisher
    ..Patients with GSTT1 deletion had tumors of more advanced stages, and those with Val432 polymorphism in CYP1B1 had tumors of higher Fuhrman grade. ..
  2. Salinas Sanchez A, Donate Moreno M, Lopez Garrido M, Giménez Bachs J, Escribano J. Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility. J Urol. 2012;187:700-6 pubmed publisher
    ..2 to 8.3. This study provides strong evidence for the role of common CYP1B1 variants as risk factors for bladder cancer, which increases with occupational exposure. ..
  3. Salinas Sanchez A, Hernández Millán I, Virseda Rodriguez J, Segura Martin M, Lorenzo Romero J, Giménez Bachs J, et al. [Problem-based learning in urology training. The Faculty of Medicine of the Universidad de Castilla-La Mancha model]. Actas Urol Esp. 2005;29:8-15 pubmed
    ....
  4. Salinas Sanchez A, Lorenzo Romero J, Giménez Bachs J, Sanchez Sanchez F, Donate Moreno M, Rubio Del Campo A, et al. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study. Urol Oncol. 2008;26:620-6 pubmed publisher
    ..Nevertheless, the classic prognostic factors (primarily, pTNM stage) should still be considered the most useful factors for follow-up of these patients. ..